May 05, 2022 at 9:44 pm

Axogen (AXGN) Rallies On Positive Phase 3 Data

Axogen shares jumped 18% upon announcing that their Phase 3 study comparing Avance to conduits in digital nerve injuries met its primary endpoint for the return of sensory function. Axogen noted that the results mark a critical milestone toward transitioning Avance to a licensed biologic and supporting adoption of the product. “We are thrilled that… [Read More]
May 04, 2022 at 9:37 pm

Livent Corporation (LTHM) Shoots Up 30% on Positive Earnings

Livent Corporation (LTHM) reported earnings, where they posted a net profit of $53.2 million, compared to a loss of $800,000 a year ago. LTHM also beat Wall Street expectations for its first quarter, and raised its guidance for the year. The Company attributed the success to a rising demand and prices for lithium, which is… [Read More]
May 02, 2022 at 9:46 pm

Athersys (ATHX) Soars 16% Ahead of Earnings

Athersys (ATHX) Soared 16.4% today ahead of their earnings date coming up on Friday, May 6th. In addition, the CEO Daniel Camardo recently bought 132,800 shares of the Company’s stock on March 17th at an average price of $0.77. Institutional investors have also made recent acquisitions, which may be a positive sign for the Company in the… [Read More]
April 29, 2022 at 5:47 pm

Anixa Biosciences (ANIX) Jumps Almost 20% Despite Overall Market Losses

Despite a rough day in the market overall, Anixa Biosciences (ANIX) managed to leap almost 20% for the day. The Company announced a presentation outlining the design of its breast cancer vaccine trial at the American Society of Clinical Oncology Meeting, which is being held in early June. The presentation, titled “Phase 1 Trial of… [Read More]
April 27, 2022 at 8:58 pm

PAVmed Inc (PAVM) Jumps 16.5%

On an overall negative day for the PRISM Stock Indexes, PAVmed stood out with a very positive day. PAVM jumped 16.5%, ending with a share price of $1.27 and a daily high of around $1.40. PAVM is located in the MedDevices and MedDiagnostics indexes, which finished -1.2% and -0.2%, respectively. PAVM announced yesterday, that the… [Read More]
April 26, 2022 at 6:39 pm

Why Quoin Stock Jumped 40% Yesterday

Quoin (Nasdaq:QNRX), a boutique biotech developing and commercializing treatments for rare skin diseases, shared the notable news that it has received FDA clearance to begin clinical testing for its new Investigational New Drug (IND) to treat Netherton Syndrome, a rare and devastating genetic disease with no cure or approved treatment. “We are extremely pleased to… [Read More]
April 26, 2022 at 5:04 pm

LogicBio Therapeutics (LOGC) Among Worst Performing On the Nasdaq

LogicBio Therapeutics (LOGC) fell almost 26% for the day, which was among the worst losses on the Nasdaq. LogicBio Therapeutics is a clinical-stage genetic medicine company working on genome editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood. LOGC is housed in the PRISM Gene Therapy Index, which also… [Read More]
April 25, 2022 at 10:18 pm

NVAX Climbs Almost 8% For the Day

Novavax (NVAX) rose around 8% on the news of a new study; a Covid-19 booster study in adolescents aged between 12 and 17 years old. Initial data from the pediatric expansion study is anticipated during the second half of 2022. The objectives of the study will assess the humoral immune response in participants after 28… [Read More]
April 22, 2022 at 7:17 pm

PRISM Emerging Uranium Index Takes a Hit

The PRISM Emerging Uranium Index tumbled nearly 7% on Friday, on an overall negative day. The losses were lead by Uranium Energy Corp. (UEC), which was down nearly 12% for the day. UEC’s losses follow positive news two days ago, where UEC announced that it has secured an additional 400,000 pounds of U.S. warehoused uranium,… [Read More]
April 21, 2022 at 6:10 pm

Pulse Biosciences (PLSE) Shoots Up 16%

The significant rise in stock price follows a rights offering that was announced a week ago. Pulse announced its intention to issue”non-transferable subscription rights to its stockholders of record as of the Record Date to purchase up to $15,000,000 of units (the “Units,” and each, a “Unit”) at a subscription price per Unit equal to… [Read More]
April 21, 2022 at 5:52 pm

Voyager Therapeutics Plunges as Board Members Leave

Voyager Therapeutics (VYGR) takes a 28% dive on Thursday following the news that two its board members had requested not to be nominated for re-election in the upcoming annual shareholder meeting. The reasoning provided, was that the duo needed to cut work commitments. The two board members confirmed that “such request was not based upon… [Read More]
April 20, 2022 at 1:37 pm

Bulls, Bears, and the Retail Investor Effect

The puppet master speaks and the dolls dance upon a string. That’s what happened this week when the stock market’s master of manipulation, Elon Musk, announced his $43 billion takeover bid for Twitter (TWTR). Retail investors went wild over it, sparking a buying frenzy that saw the stock price jump 7.5% in a single session… [Read More]